Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Lucas Dean is a surgical researcher whose work bridges the gap between innovative imaging technology and practical, evidence-based perioperative care. His primary research focuses on fluorescence-guided surgery, specifically the clinical application of Rizedisben, a novel myelin-binding fluorophore that activates under blue light (370-425 nm) to enhance intraoperative nerve identification. This contribution is critical for minimizing nerve damage during procedures like prostatectomy, offering a tangible step forward in precision surgery. Complementing this, Dr. Dean has also conducted impactful work on postoperative care protocols. His 2019 study on routine hemoglobin assessment after minimally invasive radical prostatectomy demonstrated that such checks poorly predict transfusion needs, challenging standard practices and advocating for more targeted, cost-effective monitoring. While his citation counts are modest—reflecting a career in its early, high-impact stages—his work on Rizedisben (2025) has already garnered attention for its potential to reduce surgical morbidity. Dr. Dean’s research is notable for its direct clinical applicability, aiming to make surgery both safer and more efficient.